Abstract
Artificial intelligence (AI) enables the diabetic patient's symptoms and biomarkers to be monitored. People with diabetes are weak, and if a COVID-19 infection is present, the patient must be managed optimally, with a focus on fighting the virus while simultaneously maintaining homeostasis and glycemic control. This study examines the present state of knowledge and limitations in using AI to prevent and manage individuals with diabetes and COVID-19 infection. Furthermore, patient engagement in diabetes care is improved by media and online. These innovative technological advancements have improved glycemic management by lowering fasting and by tracking postprandial glucose levels and glycosylated haemoglobin. In this pandemic period, glycemic management and the implementation of suitable interventions are crucial considerations for diabetic patients, particularly those with an active illness. More research is needed in the future to provide care for diabetic patients' psychological and nutritional well-being as well as to reduce their healthcare costs by building focused AI systems.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: International Journal of Operations Research and Information Systems
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
